GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Conditions:   Immunization;   Efficacy;   Human Papilloma Virus Interventions:   Biological: 9-valent HPV vaccine, 2 dose efficacy;   Biological: 9-valent HPV vaccine, 3 doses standard timing Sponsors:   The University of Texas Medical Branch, Galveston;   Cancer Prevention Research Institute of Texas Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials